Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

EMEA All Vaccine Report for Period 2017 till 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the bodys immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or wild pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).


Scope of the Report:
This report focuses on the All Vaccine in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR S.A.
Novartis
GSK

Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Other

Market Segment by Applications, can be divided into
For Adult
For Child

There are 13 Chapters to deeply display the EMEA All Vaccine market.

Chapter 1, to describe All Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of All Vaccine, with sales, revenue, and price of All Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of All Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, All Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe All Vaccine research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 All Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Varicella
1.2.2 Influenza
1.2.3 Polio
1.2.4 Hepatitis A
1.2.5 Rabies
1.2.6 BCG
1.2.7 Hepatitis B
1.2.8 Pertussis, Diphtheria, tetanus
1.2.9 Pneumococcal
1.2.10 Other
1.3 Market Analysis by Applications
1.3.1 For Adult
1.3.2 For Child
1.4 Market Analysis by Regions
1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
1.4.1.1 Germany Market States and Outlook (2012-2022)
1.4.1.2 France Market States and Outlook (2012-2022)
1.4.1.3 UK Market States and Outlook (2012-2022)
1.4.1.4 Italy Market States and Outlook (2012-2022)
1.4.1.5 Russia Market States and Outlook (2012-2022)
1.4.1.6 Turkey Market States and Outlook (2012-2022)
1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
1.4.2.2 UAE Market States and Outlook (2012-2022)
1.4.2.3 Israel Market States and Outlook (2012-2022)
1.4.2.4 Iran Market States and Outlook (2012-2022)
1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
1.4.3.1 South Africa Market States and Outlook (2012-2022)
1.4.3.2 Nigeria Market States and Outlook (2012-2022)
1.4.3.3 Egypt Market States and Outlook (2012-2022)
1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CNBG
2.1.1 Business Overview
2.1.2 All Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CNBG All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ChengDa Bio
2.2.1 Business Overview
2.2.2 All Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 ChengDa Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Changsheng Life
2.3.1 Business Overview
2.3.2 All Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Changsheng Life All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zhifei
2.4.1 Business Overview
2.4.2 All Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Zhifei All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 SINOVAC BIOTECH
2.5.1 Business Overview
2.5.2 All Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 SINOVAC BIOTECH All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 NuoCheng Bio
2.6.1 Business Overview
2.6.2 All Vaccine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 NuoCheng Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
2.7.1 Business Overview
2.7.2 All Vaccine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Hualan Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kangtai
2.8.1 Business Overview
2.8.2 All Vaccine Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Kangtai All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SANOFI PASTEUR S.A.
2.9.1 Business Overview
2.9.2 All Vaccine Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 SANOFI PASTEUR S.A. All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 All Vaccine Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Novartis All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
2.11.1 Business Overview
2.11.2 All Vaccine Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 GSK All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA All Vaccine Market Competition, by Manufacturer
3.1 EMEA All Vaccine Sales and Market Share by Manufacturer
3.2 EMEA All Vaccine Revenue and Market Share by Manufacturer
3.3 EMEA All Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 All Vaccine Manufacturer Market Share
3.4.2 Top 5 All Vaccine Manufacturer Market Share
3.5 Market Competition Trend
4 EMEA All Vaccine Market Analysis by Regions
4.1 EMEA All Vaccine Sales, Revenue and Market Share by Regions
4.1.1 EMEA All Vaccine Sales by Regions (2012-2017)
4.1.2 EMEA All Vaccine Revenue by Regions (2012-2017)
4.2 Europe All Vaccine Sales and Growth (2012-2017)
4.3 Middle East All Vaccine Sales and Growth (2012-2017)
4.4 Africa All Vaccine Sales and Growth (2012-2017)
5 Europe All Vaccine by Countries, Type, Application and Manufacturers
5.1 Europe All Vaccine Sales, Revenue and Market Share by Countries
5.1.1 Europe All Vaccine Sales by Countries (2012-2017)
5.1.2 Europe All Vaccine Revenue by Countries (2012-2017)
5.1.3 Germany All Vaccine Sales and Growth (2012-2017)
5.1.4 France All Vaccine Sales and Growth (2012-2017)
5.1.5 UK All Vaccine Sales and Growth (2012-2017)
5.1.6 Russia All Vaccine Sales and Growth (2012-2017)
5.1.7 Italy All Vaccine Sales and Growth (2012-2017)
5.1.8 Turkey All Vaccine Sales and Growth (2012-2017)
5.2 Europe All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 Europe All Vaccine Sales by Manufacturers (2016-2017)
5.2.2 Europe All Vaccine Revenue by Manufacturers (2016-2017)
5.3 Europe All Vaccine Sales by Type (2012-2017)
5.4 Europe All Vaccine Sales by Application (2012-2017)
6 Middle East All Vaccine by Countries, Type, Application and Manufacturers
6.1 Middle East All Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Middle East All Vaccine Sales by Countries (2012-2017)
6.1.2 Middle East All Vaccine Revenue by Countries (2012-2017)
6.1.3 Saudi Arabia All Vaccine Sales and Growth (2012-2017)
6.1.4 Israel All Vaccine Sales and Growth (2012-2017)
6.1.5 UAE All Vaccine Sales and Growth (2012-2017)
6.1.6 Iran All Vaccine Sales and Growth (2012-2017)
6.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
6.3 Middle East All Vaccine Sales by Type (2012-2017)
6.4 Middle East All Vaccine Sales by Application (2012-2017)
7 Africa All Vaccine by Countries, Type, Application and Manufacturers
7.1 Africa All Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Africa All Vaccine Sales by Countries (2012-2017)
7.1.2 Africa All Vaccine Revenue by Countries (2012-2017)
7.1.3 South Africa All Vaccine Sales and Growth (2012-2017)
7.1.4 Nigeria All Vaccine Sales and Growth (2012-2017)
7.1.5 Egypt All Vaccine Sales and Growth (2012-2017)
7.1.6 Algeria All Vaccine Sales and Growth (2012-2017)
7.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
7.3 Middle East All Vaccine Sales by Type (2012-2017)
7.4 Middle East All Vaccine Sales by Application (2012-2017)
8 EMEA All Vaccine Market Segment by Type
8.1 EMEA All Vaccine Sales, Revenue and Market Share by Type (2012-2017)
8.1.1 EMEA All Vaccine Sales and Market Share by Type (2012-2017)
8.1.2 EMEA All Vaccine Revenue and Market Share by Type (2012-2017)
8.2 Varicella Sales Growth and Price
10.2.1 EMEA Varicella Sales Growth (2012-2017)
10.2.2 EMEA Varicella Price (2012-2017)
8.3 Influenza Sales Growth and Price
10.3.1 EMEA Influenza Sales Growth (2012-2017)
10.3.2 EMEA Influenza Price (2012-2017)
8.4 Polio Sales Growth and Price
10.4.1 EMEA Polio Sales Growth (2012-2017)
10.4.2 EMEA Polio Price (2012-2017)
8.5 Hepatitis A Sales Growth and Price
10.5.1 EMEA Hepatitis A Sales Growth (2012-2017)
10.5.2 EMEA Hepatitis A Price (2012-2017)
8.6 Rabies Sales Growth and Price
10.6.1 EMEA Rabies Sales Growth (2012-2017)
10.6.2 EMEA Rabies Price (2012-2017)
8.7 BCG Sales Growth and Price
10.7.1 EMEA BCG Sales Growth (2012-2017)
10.7.2 EMEA BCG Price (2012-2017)
8.8 Hepatitis B Sales Growth and Price
10.8.1 EMEA Hepatitis B Sales Growth (2012-2017)
10.8.2 EMEA Hepatitis B Price (2012-2017)
8.9 Pertussis, Diphtheria, tetanus Sales Growth and Price
10.9.1 EMEA Pertussis, Diphtheria, tetanus Sales Growth (2012-2017)
10.9.2 EMEA Pertussis, Diphtheria, tetanus Price (2012-2017)
8.10 Pneumococcal Sales Growth and Price
10.10.1 EMEA Pneumococcal Sales Growth (2012-2017)
10.10.2 EMEA Pneumococcal Price (2012-2017)
8.11 Other Sales Growth and Price
8.11.1 EMEA Other Sales Growth (2012-2017)
8.11.2 EMEA Other Price (2012-2017)
9 EMEA All Vaccine Market Segment by Application
9.1 EMEA All Vaccine Sales Market Share by Application (2012-2017)
9.2 For Adult Sales Growth (2012-2017)
9.3 For Child Sales Growth (2012-2017)
10 EMEA All Vaccine Market Forecast (2017-2022)
10.1 EMEA All Vaccine Sales, Revenue and Growth Rate (2017-2022)
10.2 All Vaccine Market Forecast by Regions (2017-2022)
10.2.1 Europe All Vaccine Market Forecast by Regions (2017-2022)
10.2.1.1 Germany All Vaccine Sales Forecast 2017-2022
10.2.1.2 France All Vaccine Sales Forecast 2017-2022
10.2.1.3 UK All Vaccine Sales Forecast 2017-2022
10.2.1.4 Russia All Vaccine Sales Forecast 2017-2022
10.2.1.5 Italy All Vaccine Sales Forecast 2017-2022
10.2.1.6 Turkey All Vaccine Sales Forecast 2017-2022
10.2.2 Middle East Market Forecast by Regions (2017-2022)
10.2.2.1 Saudi Arabia All Vaccine Sales Forecast 2017-2022
10.2.2.2 Israel All Vaccine Sales Forecast 2017-2022
10.2.2.3 UAE All Vaccine Sales Forecast 2017-2022
10.2.2.4 Iran All Vaccine Sales Forecast 2017-2022
10.2.3 Africa Market Forecast by Regions (2017-2022)
10.2.3.1 South Africa All Vaccine Sales Forecast 2017-2022
10.2.3.2 Nigeria All Vaccine Sales Forecast 2017-2022
10.2.3.3 Egypt All Vaccine Sales Forecast 2017-2022
10.2.3.4 Algeria All Vaccine Sales Forecast 2017-2022
10.3 All Vaccine Market Forecast by Type (2017-2022)
10.4 All Vaccine Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
11.1 Sales Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 34038

Category: 16

Published date: 2017-10-02 18:09:59

Number of Pages: 141

Publisher Name: GIR

Over all Rating: 96 % (Average of Ratings provided by clients)